S-100A5 inhibitors represent a diverse class of chemical compounds that are specifically designed to modulate the activity of the S-100A5 protein. S-100A5 is a member of the S-100 protein family, a group of small, calcium-binding proteins known for their involvement in various cellular processes. S-100A5, in particular, plays a role in calcium signaling and has been associated with several physiological functions, including neuronal development, cell proliferation, and apoptosis. Consequently, the development of inhibitors targeting S-100A5 is of considerable interest in elucidating its precise functions within cellular pathways.
These inhibitors exert their effects primarily by interfering with the activity of S-100A5 through different mechanisms. Some inhibitors, such as KN-93, act by blocking the calcium/calmodulin-dependent protein kinase II (CaMKII), which phosphorylates and activates S-100A5. Others, like SB-203580, indirectly inhibit S-100A5 by targeting upstream signaling molecules like p38 MAP kinase, blocking the phosphorylation of S-100A5. Additionally, compounds like A-485, which are histone deacetylase (HDAC) inhibitors, may indirectly influence S-100A5 by modulating the acetylation status of proteins that interact with S-100A5. This chemical class showcases the versatility of approaches employed to regulate S-100A5's functions, highlighting the complex network of pathways associated with this protein. Further research into the specific mechanisms and consequences of S-100A5 inhibition could provide valuable insights into its role in cellular biology and applications.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
KN-93 inhibits S-100A5 by blocking the calcium/calmodulin-dependent protein kinase II (CaMKII), which regulates S-100A5 phosphorylation and activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB-203580 is a p38 MAP kinase inhibitor that indirectly inhibits S-100A5 by blocking its phosphorylation via p38 MAP kinase. | ||||||
A-485 | 1889279-16-6 | sc-507493 | 5 mg | $275.00 | ||
A-485 is a histone deacetylase (HDAC) inhibitor that affects S-100A5 by modulating the acetylation status of its interacting proteins. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
BAPTA-AM chelates intracellular calcium ions, indirectly inhibiting S-100A5 by disrupting its calcium-dependent functions. | ||||||
A-803467 | 944261-79-4 | sc-201068 sc-201068B sc-201068A | 10 mg 25 mg 50 mg | $87.00 $184.00 $342.00 | 1 | |
A-803467 is a selective Nav1.8 sodium channel blocker, which indirectly influences S-100A5 through neuronal signaling pathways. | ||||||
GW3965 | 405911-09-3 | sc-490151 sc-490151A sc-490151B | 10 mg 50 mg 1 g | $260.00 $872.00 $1637.00 | ||
GW3965 is a liver X receptor (LXR) agonist that may affect S-100A5 expression through LXR-mediated transcriptional regulation. | ||||||
TBB | 17374-26-4 | sc-202830 sc-202830A sc-202830C sc-202830B sc-202830D | 10 mg 25 mg 50 mg 100 mg 250 mg | $240.00 $363.00 $445.00 $760.00 $1781.00 | 17 | |
TBB is a casein kinase 2 (CK2) inhibitor, potentially inhibiting S-100A5 phosphorylation by CK2, thereby affecting its activity. | ||||||
SB 265610 | 211096-49-0 | sc-361341 sc-361341A | 1 mg 10 mg | $81.00 $209.00 | ||
SB-265610 is a CXCR2 antagonist, which indirectly influences S-100A5 expression through chemokine receptor signaling pathways. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $178.00 $325.00 | 67 | |
MK-2206 is an Akt inhibitor that may impact S-100A5 activity through the PI3K/Akt signaling pathway. | ||||||
CGP 57380 | 522629-08-9 | sc-202993 | 5 mg | $172.00 | 6 | |
CGP-57380 inhibits p21-activated kinase 4 (PAK4), which indirectly affects S-100A5 through PAK4-mediated signaling pathways. | ||||||